Vik

4 articles

About Vik coverage

The Vik news hub on Global Investing News tracks 4 recent headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Vik developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Vik across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.

Explore related topics

AI Streaming Video Tech Crypto EV Economy Cloud Semiconductors Entertainment Mobile Markets Business

Latest Vik headlines

Market Data

(1)

Ex-Viking Manager Nettimi Gains Over 20% for Third Straight Year

Mala Gaonkar’s SurgoCap Partners, led by the former Viking Global Investors executive, has achieved an impressive third consecutive year of returns exceeding 20%. This performance is particularly notable as it occurs against a backdrop of volatile interest rate environments and a bifurcated equity market where many long/short managers have struggled to keep pace with the S&P 500's tech-driven rally. SurgoCap’s success underscores a persistent trend in the hedge fund industry: the 'Tiger Cub' lineage continues to produce top-tier talent capable of generating alpha through concentrated, fundamental-based stock picking. The fund’s ability to navigate the 2023-2024 AI-driven surge while maintaining risk management protocols suggests a sophisticated approach to the technology and healthcare sectors. For institutional investors, this streak validates the move toward boutique, specialized firms over massive multi-strategy platforms that have faced mounting fee and performance scrutiny. Looking ahead, the key for SurgoCap will be maintaining this trajectory as assets under management (AUM) likely swell following this high-profile performance, testing the scalability of Gaonkar’s investment thesis in a potentially softening macro environment.

Bloomberg•10 months ago

Other Sources

(3)

Novo Nordisk’s weight-loss pill is available. Here’s why Lilly’s and Viking’s stocks are down.

Novo Nordisk has launched its oral weight-loss drug, likely creating significant competition for pharmaceutical companies developing similar treatments. The availability of Novo Nordisk's pill, which offers a convenient administration route, is raising concerns among investors about the future market share for Eli Lilly and Viking Therapeutics, whose stock prices have dropped as a result.

MarketWatch•10 months ago

Viktor Shvets on the Case for EU Exceptionalism

This Bloomberg headline likely refers to Viktor Shvets' analysis suggesting that the European Union possesses unique inherent strengths or advantages that will allow it to outperform or distinguish itself from other major global economies or blocs, despite various challenges. This exceptionalism could stem from its regulatory framework, social contract, or other structural advantages.

Bloomberg•10 months ago

Jim Cramer on Viking Holdings: “That Is My Favorite”

Jim Cramer, a well-known financial commentator, expressed strong enthusiasm for Viking Holdings (VIK), stating it's his 'favorite' stock. This endorsement likely comes after Viking's strong debut on the New York Stock Exchange, where it raised $1.3 billion and soared nearly 20% on its first day of trading, indicating significant investor interest in the luxury cruise line operator.

Yahoo Finance•11 months ago

Get alerts for this topic

Subscribe to receive updates about "Vik"

Vik